Browse by Industry
Filter News
Found 19,400 articles
-
LUNGevity Foundation Kicks Off New Marketing Campaign to Raise Awareness of the Impact of Lung Cancer
6/13/2018
"234" asks the public to help change lung cancer statistics
-
Nicole Fevrier Davis Opens New MindBody Mastery Studio and Adds Psychic Assessments and Neurofeedback to her List of Unique Fitness Training Services
5/1/2018
Psychic personal trainer Nicole Fevrier Davis is slated to open her new studio at 10 Roberts Lane in Ridgefield CT on May 2nd.
-
The week of June 18 to June 22 was bookended by big hiring announcement in the pharma industry. It began with a former Cowen analyst being tapped as chief financial officer of startup Allogene and ended with the retirement announcement of the group worldwide chairman at Johnson & Johnson.
-
Roche announced that its Phase III IMpower 133 clinical trial of Tecentriq (atezolizumab) plus carboplatin and etoposide chemotherapy met its co-primary endpoints.
-
FDA Action Alert: It's a Big Week
6/25/2018
It’s a big week for the U.S. Food and Drug Administration (FDA) with plenty of upcoming decisions including Achaogen, GW Pharma, Merck and more. -
AbbVie is taking another shot at solid tumor treatments through a collaboration with Calibr.
-
Lyme disease is the most common tick-borne disease in the U.S. There are approximately 300,000 cases diagnosed each year. Yet it is a disease that affects people very differently and often stymies both diagnosis and treatment.
-
A consumer advocacy group, Public Citizen, has petitioned the FDA to pull the drug, Uloric, off the market.
-
The scope of the U.S. Food and Drug Administration’s mission could become much narrower if a proposed restructuring of the federal government comes to fruition.
-
There is another change coming to the senior leadership team at Swiss pharma giant Roche.
-
Researchers from the Icahn School of Medicine at Mount Sinai evaluated data on the brains of people and found higher levels of herpes virus in the Alzheimer’s patients.
-
As a female chief executive officer in the healthcare industry Karen Zaderej often stands out in a male-dominated industry.
-
For type 1 narcolepsy, this sleep-wake instability is linked to low levels of hypocretin, also called orexin. Hypocretin is a neurotransmitter produced in the hypothalamus and has a significant role in wakefulness and regulating rapid eye movement (REM) sleep. But Harmony Biosciences has found an...
-
Concerns Rise Over Negative Impact of HEV Light on Skin as Companies Delve Into Anti-Aging Therap...
6/22/2018
Something that most everyone does multiple times a day may not be as care-free as initially thought. Taking a selfie with a smart phone can actually be harmful to your skin. -
After waiting with bated breath, Johnson & Johnson Innovation finally opened its New York City JLABS facility with 26 resident companies, including the four winners of the JLABS @ NYC QuickFire Challenge.
-
Autolus Brings in $150 Million in IPO, Continues Strong Investment Trend for Biotechs This Week
6/22/2018
Autolus Therapeutics snagged $150 million from its initial public offering, about $25 million more than the company initially expected when it began its roadshow effort earlier this month. -
June 22 Research Roundup: Diabetes, Spinal Injury, Pancreatic Cancer and Cardiovascular Disease
6/22/2018
There are plenty of great scientific research stories out this week including a possible cure for diabetes, healing spinal injury and more. -
Nanobiotix announced positive topline data from its Phase II/III clinical trial of NBTXR3 in soft tissue sarcoma (STS). Shares climbed by more than 50 percent at the news.
-
Hkbu Scholars Invent Award-winning Medical Device for Safe Growth of Neural Stem Cells Using Nanotechnology
6/22/2018
The research team of Hong Kong Baptist University (HKBU) invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells (NSCs) in vitro.
-
ThromboGenics Partners with Prevent Blindness at 2018 Focus on Eye Health National Summit in Washington DC
6/22/2018
ThromboGenics NV announces its participation and support of the seventh annual Prevent Blindness Focus on Eye Health National Summit